SODIUM-DEPENDENT NORADRENALINE TRANSPORTER

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 21:26:13 GMT 2025` Edited by `admin` on `Tue Apr 01 21:26:13 GMT 2025`
Protein Type	TRANSPORTER
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	HN86OLH1NW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SODIUM-DEPENDENT NORADRENALINE TRANSPORTER

Common Name

English

NAT1

Preferred Name

English

NOREPINEPHRINE TRANSPORTER

Common Name

English

NET1

Common Name

English

SLC6A5

Common Name

English

NET

Common Name

English

SOLUTE CARRIER FAMILY 6 MEMBER 2

Common Name

English

SLC6A2

Common Name

English

Code System Code Type Description

WIKIPEDIA

Norepinephrine transporter

Created by admin on Tue Apr 01 21:26:14 GMT 2025 , Edited by admin on Tue Apr 01 21:26:14 GMT 2025

PRIMARY

FDA UNII

HN86OLH1NW

Created by admin on Tue Apr 01 21:26:14 GMT 2025 , Edited by admin on Tue Apr 01 21:26:14 GMT 2025

PRIMARY

UNIPROT

P23975

Created by admin on Tue Apr 01 21:26:14 GMT 2025 , Edited by admin on Tue Apr 01 21:26:14 GMT 2025

PRIMARY

From	To
1_176	1_185

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_184
N	1_192
N	1_198

Related Record Type Details


					ASW034S0B8

ATOMOXETINE

INHIBITOR -> TARGET

Amount:


					1806D8D52K

Amitriptyline

INHIBITOR -> TARGET


					3947754WXW

MIDOMAFETAMINE, (R)-

WEAK INHIBITOR->OFF TARGET

Qualification:

IC50

Amount:


					VA46LC5AZQ

MENET C-11

RADIOLIGAND->TARGET

Amount:


					PFW9A4FSE8

1-(2,6-DIFLUOROPHENYL)-3-(2-PIPERAZIN-1-YLETHYL)-1,3-DIHYDRO-2,1,3-BENZOTHIADIAZOLE 2,2-DIOXIDE

INHIBITOR -> TARGET

Amount:


					Q362RQ92NG

Ro-035939 free base

INHIBITOR -> TARGET

Amount:


					J6EIG6Q478

RO-15-8081 FREE BASE

INHIBITOR -> TARGET

Amount:


					HY5T9WKI4O

DESVENLAFAXINE, (-)-

INHIBITOR -> TARGET

Amount:


					8AAP8G8ODE

INER I-123

RADIOLIGAND->TARGET


					3RHE5Z6TXP

Nisoxetine H-3

RADIOLIGAND->TARGET

Qualification:

Amount:


					4NDU154T12

PROTRIPTYLINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					G905IN29U4

BELOXEPIN

INHIBITOR -> TARGET


					26J30IC20Q

TRAMADOL, (-)-

INHIBITOR -> TARGET


					7KN3H3NMW6

WF-23

INHIBITOR -> TARGET

Amount:


					O5TNM5N07U

Duloxetine

INHIBITOR -> TARGET


					R3TC4SEW5A

Clemeprol

INHIBITOR -> TARGET

Amount:


					285VE60914

6-APB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					532Y5K4NMA

RTI-120

INHIBITOR -> TRANSPORTER

Amount:


					V3H1ZVV9S6

Norquetiapine

INHIBITOR -> TARGET

Qualification:

Amount:


					VFB6950Q3Y

3-HYDROXYEPHEDRINE, C-11

RADIOLIGAND->TARGET

Amount:


					H8A007M585

TAPENTADOL

INHIBITOR -> TARGET

Amount:


					39J1LGJ30J

TRAMADOL

INHIBITOR -> TARGET

Comments:

(?)-tramadol inhibits norepinephrine reuptake

Amount:


					2M3825704H

5-APB

INHIBITOR -> TARGET

Qualification:

Amount:


					Q461L7AK4R

IOBENGUANE I-131

SUBSTRATE -> TARGET


					HMC2H89N35

NIRAPARIB

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO

Qualification:

IC50

Amount:


					P7G9TGX966

GMO C-11

RADIOLIGAND->TARGET

Amount:


					GRZ5RCB1QG

VENLAFAXINE

INHIBITOR -> TARGET

Amount:


					19997EZ42I

AMPRELOXETINE

INHIBITOR -> TARGET


					NG99554ANW

DESVENLAFAXINE

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					L4I4B1R01F

MDMC

INHIBITOR -> TARGET

Amount:


					44MR98LU8P

MENER, (S,S)-C-11

RADIOLIGAND->TARGET

Amount:


					V9MLT2S334

PRC200-SS

INHIBITOR -> TRANSPORTER

Amount:


					8LF7W971UM

FLUBROBENGUANE F-18

RADIOLIGAND->TARGET

Amount:


					99T4HMN9HV

WY-46824

INHIBITOR -> TRANSPORTER

Amount:


					54U9UN7HN4

DIPHENYLPROLINOL

INHIBITOR -> TARGET

Amount:


					K8J4W658QK

2'-HYDROXYCOCAINE

LIGAND->TRANSPORTER

Amount:


					C6C3GB68TV

N-METHYL-PPPA

INHIBITOR -> TRANSPORTER

Amount:


					90X28IKH43

VANOXERINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					W6I5QDT7QI

NETARSUDIL

INHIBITOR -> TARGET


					3LEH2E7AEU

1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine

INHIBITOR -> TRANSPORTER

Amount:


					939U7C91AI

Solriamfetol

INHIBITOR -> TARGET

Qualification:

Amount:


					FS9Z5C7CQ5

3-METHYL-PCPY

INHIBITOR -> TRANSPORTER


					L9NG7US8GE

Pudafensine

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					HNZ7L49KE6

DPIA

WEAK INHIBITOR->TARGET

Comments:

The weak monoaminergic activity of DPIA suggest no major pharmacological contribution when present in street amphetamine

Amount:


					OGG85SX4E4

IMIPRAMINE

INHIBITOR -> TARGET

Amount:


					X72T4EQ4FQ

BUTYLONE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Z8L8DWV2EK

AF-78 F-18

RADIOLIGAND->TARGET

Comments:

Transport affinity almost identical to norepinephrine.

Qualification:

IC50

Amount:


					TG537D343B

DESIPRAMINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					TDD7WP3S39

RTI-112

INHIBITOR -> TRANSPORTER

Interaction Type:

IN-VITRO


					Z0420GYD84

TUAMINOHEPTANE

INHIBITOR -> TARGET

Comments:

Could be target

Qualification:

IC50

Amount:


					B27VXE4GHR

PSN-602

INHIBITOR -> TARGET

Amount:


					3BPF2MD5QE

4F-MHPG F-18

RADIOLIGAND->TARGET

Amount:


					BIK35ACJ0Q

INDOPAN

INHIBITOR -> TARGET

Amount:


					ZXQ5PQR4TU

6-METHYL-MDA

INHIBITOR -> TRANSPORTER

Interaction Type:

IN RAT

Amount:


					KE1SEN21RM

MIDOMAFETAMINE

INHIBITOR -> TARGET

Comments:

Inhibition of [3H]Neurotransmitter Uptake

Qualification:

IC50

Amount:


					7CUC9DDI9F

PSEUDOEPHEDRINE

INHIBITOR -> TARGET


					3O2K1S3WQV

Vortioxetine

INHIBITOR -> TARGET

Qualification:

Amount:


					6L5FH5A43E

TANDAMINE

INHIBITOR -> TARGET

Amount:


					GYT6ACY5JL

JZ-IV-10

INHIBITOR -> TRANSPORTER

Amount:


					1P958G9T1V

EXP-561

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL